| Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers M Bafadhel, S McKenna, S Terry, V Mistry, C Reid, P Haldar, ... American journal of respiratory and critical care medicine 184 (6), 662-671, 2011 | 1254 | 2011 |
| Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial M Bafadhel, S McKenna, S Terry, V Mistry, M Pancholi, P Venge, ... American journal of respiratory and critical care medicine 186 (1), 48-55, 2012 | 676 | 2012 |
| Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD C Doe, M Bafadhel, S Siddiqui, D Desai, V Mistry, P Rugman, ... Chest 138 (5), 1140-1147, 2010 | 493 | 2010 |
| Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial S Ramakrishnan, DV Nicolau, B Langford, M Mahdi, H Jeffers, ... The Lancet Respiratory Medicine 9 (7), 763-772, 2021 | 451 | 2021 |
| Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials M Bafadhel, S Peterson, MA De Blas, PM Calverley, SI Rennard, ... The Lancet Respiratory Medicine 6 (2), 117-126, 2018 | 442 | 2018 |
| Lung microbiome dynamics in COPD exacerbations Z Wang, M Bafadhel, K Haldar, A Spivak, D Mayhew, BE Miller, ... European Respiratory Journal 47 (4), 1082-1092, 2016 | 413 | 2016 |
| Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study CE Brightling, ER Bleecker, RA Panettieri, M Bafadhel, D She, CK Ward, ... The Lancet Respiratory Medicine 2 (11), 891-901, 2014 | 332 | 2014 |
| Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD M Bafadhel, TW Clark, C Reid, M Medina, S Batham, MR Barer, ... Chest 139 (6), 1410-1418, 2011 | 299 | 2011 |
| Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission D Stolz, T Mkorombindo, DM Schumann, A Agusti, SY Ash, M Bafadhel, ... The Lancet 400 (10356), 921-972, 2022 | 296 | 2022 |
| Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville, O Gbinigie, ... The Lancet 398 (10303), 843-855, 2021 | 293 | 2021 |
| Benralizumab for the prevention of COPD exacerbations GJ Criner, BR Celli, CE Brightling, A Agusti, A Papi, D Singh, DD Sin, ... New England Journal of Medicine 381 (11), 1023-1034, 2019 | 239 | 2019 |
| Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma D Desai, C Newby, FA Symon, P Haldar, S Shah, S Gupta, M Bafadhel, ... American journal of respiratory and critical care medicine 188 (6), 657-663, 2013 | 239 | 2013 |
| Genome-wide association study to identify genetic determinants of severe asthma YI Wan, NRG Shrine, MS Artigas, LV Wain, JD Blakey, MF Moffatt, A Bush, ... Thorax 67 (9), 762-768, 2012 | 235 | 2012 |
| Eosinophils in COPD: just another biomarker? M Bafadhel, ID Pavord, REK Russell The Lancet Respiratory Medicine 5 (9), 747-759, 2017 | 214 | 2017 |
| An expert consensus framework for asthma remission as a treatment goal A Menzies-Gow, M Bafadhel, WW Busse, TB Casale, JWH Kocks, ... Journal of Allergy and Clinical Immunology 145 (3), 757-765, 2020 | 204 | 2020 |
| Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis M Bafadhel, L Davies, PMA Calverley, SD Aaron, CE Brightling, ID Pavord European Respiratory Journal 44 (3), 789-791, 2014 | 188 | 2014 |
| Precision medicine in airway diseases: moving to clinical practice A Agustí, M Bafadhel, R Beasley, EH Bel, R Faner, PG Gibson, R Louis, ... European Respiratory Journal 50 (4), 2017 | 187 | 2017 |
| Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease MA Ghebre, M Bafadhel, D Desai, SE Cohen, P Newbold, L Rapley, ... Journal of Allergy and Clinical Immunology 135 (1), 63-72. e10, 2015 | 183 | 2015 |
| Aspergillus fumigatus during stable state and exacerbations of COPD M Bafadhel, S Mckenna, J Agbetile, A Fairs, D Desai, V Mistry, JP Morley, ... European Respiratory Journal 43 (1), 64-71, 2014 | 180 | 2014 |
| Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease M Bafadhel, M McCormick, S Saha, S McKenna, M Shelley, B Hargadon, ... Respiration 83 (1), 36-44, 2012 | 180 | 2012 |
